Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'leu31 pro34 neuropeptide y human rat'

Search results for: 'leu31 pro34 neuropeptide y human rat'

Items 1-10 of 67

Page
per page
  1. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     19 Citation
    Target: ROCK
    Summary: ROCK1 inhibitor
      ≥111.2 mg/mL
  2. Agouti-related Protein (AGRP) (25-82), human
    A1134 Agouti-related Protein (AGRP) (25-82), human
    Target: Melanocortin (MC) Receptors
    Summary: Agouti-related peptide(25-82)
      insoluble in EtOH; insoluble in DMSO; ≥100 mg/mL
  3. Peptide YY(3-36), PYY, human
    A1115 Peptide YY(3-36), PYY, human
    Target: NPY Receptors
    Summary: Y2R agonist
      ≥405 mg/mL
  4. A-740003
    A3136 A-740003
    Target: P2X Receptors
    Summary: P2X7 receptor antagonist
      ≥23.73 mg/mL
  5. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: Human cathepsin L inhibitor,potent and reversible
      <26.98 mg/mL
  6. MK-0974
    A3612 MK-0974
    Target: CGRP receptors
    Summary: CGRP receptor antagonist
      Soluble in DMSO
  7. TAK-700 (Orteronel)
    A4326 TAK-700 (Orteronel)
     2 Citation
    Target: human lyase
    Summary: Human 17,20-lyase inhibitor
      insoluble in H2O; ≥11.2 mg/mL
  8. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    Target: Smoothened
    Summary: Smoothened inhibitor,potent and selective
      ≥24.3 mg/mL
  9. TBB
    A3861 TBB
     1 Citation
    Target: CK2
    Summary: Casein kinase-2 (CK2) inhibitor
      insoluble in H2O; ≥159.2 mg/mL
  10. ZM323881
    A3954 ZM323881
    Target: VEGFR
    Summary: VEGFR-2/KDR inhibitor,potent and selective
      Soluble in DMSO

Items 1-10 of 67

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 65item
  2. Lab Reagents 1 item
Reversibility
  1. Reversible 8item
  2. Irreversible 3item
Target
  1. Proteasome 3item
  2. Cathepsins 2item
  3. Histone Deacetylases (HDACs) 1 item
  4. CXCR 1 item
  5. Raf 1 item
  6. mTOR 1 item
  7. MMP 1 item
  8. GSK-3 1 item
  9. Factor Xa 1 item
  10. LPA Receptors 2item
  11. PLK 1 item
  12. VEGFR 1 item
  13. Bromodomain-containing proteins(BRDs) 1 item
  14. MEK 1 item
  15. CGRP receptors 1 item
  16. Smoothened 2item
  17. RARs 1 item
  18. ATP Citrate Lyases 1 item
  19. Microtubules/Tubulins 2item
  20. EGFR 3item
  21. ROCK 2item
  22. Progesterone Receptors 1 item
  23. CFTR 1 item
  24. ErbB 2item
  25. Calpains 1 item
  26. O-GlcNAcase 1 item
  27. Trypsins 1 item
  28. HER2 1 item
  29. DGAT 1 item
  30. Melanocortin (MC) Receptors 1 item
  31. RSK 1 item
  32. Free Fatty Acid Receptors 1 item
  33. CK2 1 item
  34. Melatonin Receptors 1 item
  35. P2X Receptors 1 item
  36. NPY Receptors 1 item
  37. Leukotriene and Related Receptors 1 item
  38. Histamine H1 Receptors 1 item
  39. Phospholipases 1 item
  40. HIV-1 reverse transcriptase 1 item
  41. Catechol O-Methyltransferase (COMT) 1 item
  42. Aldosterone receptor 1 item
  43. DPP-4 1 item
  44. DREADD Ligands 1 item
  45. ADAMs 1 item
  46. human lyase 1 item
  47. PPAR 1 item
  48. MSK 1 item
  49. FXR 1 item
  50. Substance P/NK1 Receptor 1 item
  51. MTH1 1 item
Related Disease
  1. Breast Cancer 12item
  2. Cancer 27item
  3. Colon Cancer 2item
  4. Colon Carcinoma 1 item
  5. Colorectal Cancer 3item
  6. Depression 1 item
  7. Diabetes 2item
  8. Glioma 1 item
  9. HIV Infections 2item
  10. Inflammatory Diseases 2item
  11. Lung Cancer 4item
  12. Mantle Cell Lymphoma 1 item
  13. Melanoma 3item
  14. Multiple Myeloma 4item
  15. Narcolepsy 1 item
  16. Neuroblastoma 1 item
  17. Non-small Cell Lung Cancer 2item
  18. Ovarian Cancer 3item
  19. Pancreatic Cancer 3item
  20. Prostate Cancer 3item
  21. Renal Cancer 1 item
  22. Renal Cell Carcinoma 1 item
  23. Sleep Disorders 2item
  24. Type 2 Diabetes 1 item